AzTrials
AzTrials

Chronic Pain, WidespreadMUD-PINCT03413501

A Multi-disciplinary Pain Intervention (MUD-PI) for Patients With Chronic Widespread Primary Pain

A study testing MUD-PI in people with Chronic Pain, Widespread, run by Oslo University Hospital.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Patients who fulfilled inclusion criteria and consented to participate received either treatment as usual at the clinic, or were enrolled in a group-therapy based intervention, the multi-disciplinary pain intervention, led by a Medical doctor, physiotherapist and psychologist at the clinic. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Chronic Pain, Widespread
What is being tested?
MUD-PI
Could I receive a placebo?
No, everyone receives an active treatment
How many people
49 participants
Where
No sites listed yet
Study dates
20 Sep 2016to 4 Jun 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18 or more
  • Pain in at least three out of five bodily regions (defined as the four quadrants and axially)
  • Pain persisting three months or more
  • The patient was able to give informed consent and benefit from group therapy (including sufficient cognitive capacity and language skills
  • No other medical condition could better explain the symptoms.

Who cannot join

None listed.

About this study

Patients who fulfilled inclusion criteria and consented to participate received either treatment as usual at the clinic, or were enrolled in a group-therapy based intervention, the multi-disciplinary pain intervention, led by a Medical doctor, physiotherapist and psychologist at the clinic.

Read the detailed description

The Department of Pain Management and Research at Oslo University Hospital is Norway's largest outpatient pain clinic. It treats around one thousand new patients annually suffering from chronic pain of all aetiologies. Many of the patients receive interdisciplinary care based on a biopsychosocial framework, by at least two health care providers (physician, physiotherapist, psychologist, occupational therapist and/or nurse).

Participants were recruited through referrals from primary or secondary care, which were identified by an established interdisciplinary team. Patients found potentially eligible for the study were contacted by the research team and consulted with a research physician. Patients who fulfilled the inclusion criteria were invited to participate in the study and signed a consent form. Patients who declined to participate and non-eligible patients received usual care.

Inclusion criteria were 1) age 18 or more; 2) pain in at least three out of five bodily regions (defined as the four quadrants and axially); 3) pain persisting three months or more; 4) the patient was able to give informed consent and benefit from group therapy (including sufficient cognitive capacity and language skills); 5) no other medical condition could better explain the symptoms.

Subjects were randomised either to treatment as usual or a group-based multidisciplinary pain intervention (the MUD-PI).

Being tested
MUD-PI
Medical subject headings
Chronic Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MUD-PIBehavioural

Study groups in NCT03413501
Study groupRoleWhat they receive
Treatment as usualNo interventionReceives treatment as usual at the clinic
MUD-PIExperimentalReceives multi-disciplinary pain intervention, agroup-based, multi-disciplinary treatment
Receives: Behavioral: MUD-PI

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Patient generated index

    Individualised patient reported outcome

    Measured: Change in score on inclusion and 1 week after completion of intervention or control group

Secondary outcomes (2)
  1. Change in EQ-5D

    standardised patient reported outcome

    Measured: Change in score on inclusion and 1 week after completion of intervention or control group

  2. Change in Oswestry disability index

    standardised patient reported outcome

    Measured: Change in score on inclusion and 1 week after completion of intervention or control group

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jan 2018
  2. Study start20 Sep 2016
  3. Primary completion20 Mar 2017
  4. Study completion4 Jun 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
49 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03413501
Sponsor's protocol ID
OsloUH Smerteklinikken
Acronym
MUD-PI
Status last verified
Dec 2023
First submitted
17 Dec 2017
Last updated
6 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Tschudi-Madsen H, Rodevand LN, Boymo Kaarbo M, Granan LP. Chronic Widespread Pain in a tertiary pain clinic: classification overlap and use of a patient generated quality of life instrument. Scand J Pain. 2019 Apr 24;19(2):245-255. doi: 10.1515/sjpain-2018-0097.

    PubMed 30465720

Questions about this trial

What is this clinical trial studying?

A study testing MUD-PI in people with Chronic Pain, Widespread, run by Oslo University Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Patient generated index (time frame: Change in score on inclusion and 1 week after completion of intervention or control group). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03413501, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Dec 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in